Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (8,812)	$ (37,738)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	6,727	7,101
Amortization of intangible assets	8,491	8,425
Reduction in carrying amount of right-of-use asset	4,038	4,317
Provision for doubtful accounts		401
Share-based compensation	8,302	8,834
Deferred income taxes	312	357
Non-cash restructuring and impairment charges		3,839
Non-cash interest expense	1,103	904
Other	1,380	(78)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	(910)	33,490
Inventories	6,628	(2,108)
Prepaid expenses and other assets	(1,521)	(486)
Accounts payable	10,628	(11,198)
Accrued compensation and benefits	(5,482)	(10,277)
Operating lease liabilities	(4,812)	(4,631)
Deferred revenue	6,607	2,001
Other current and long-term liabilities	(7,934)	(3,355)
Net cash provided by (used in) operating activities	24,745	(202)
Cash flows from investing activities:
Capital expenditures	(3,023)	(5,239)
Business acquisitions, net of cash acquired		(219,458)
Maturities and sales of investments		15,503
Net cash used in investing activities	(3,023)	(209,194)
Cash flows from financing activities:
Borrowings under Term Loan		199,500
Payments on debt obligations	(24,750)	(20,099)
Loan fees on borrowings		(10,515)
Proceeds from issuance of common stock, net of tax withholding	3,581	4,136
Payment of contingent consideration obligations	(603)	(635)
Deferred payments on an acquisition	(1,000)	(1,000)
Net cash (used in) provided by financing activities	(22,772)	171,387
Foreign currency effect on cash	294	(229)
Net decrease in cash	(756)	(38,238)
Cash at beginning of period	193,872	169,607
Cash and cash equivalents at end of period	$ 193,116	$ 131,369